Disulfide isoforms of recombinant glia maturation factor beta

Area of Science:

• Biochemistry
• Molecular Biology
• Protein Chemistry

Background:

• Recombinant human glia maturation factor beta (r-hGMF-beta) is a 141-amino acid polypeptide.
• It contains three cysteine residues at positions 7, 86, and 95.
• The nascent, reduced form of r-hGMF-beta lacks biological activity.

Purpose of the Study:

• To investigate the activation mechanism of r-hGMF-beta.
• To identify the specific isoform of r-hGMF-beta that possesses biological activity.
• To determine the disulfide bond arrangement in the active form.

Main Methods:

• Oxidative refolding using a glutathione mixture.
• Reverse-phase High-Performance Liquid Chromatography (HPLC) for isoform separation.
• Biological activity testing on C6 glioma cells for growth suppression.

Main Results:

• Oxidative refolding generated four distinct r-hGMF-beta isoforms, including the reduced form.
• Only one of the refolded isoforms exhibited growth suppressive activity on C6 glioma cells.
• HPLC analysis indicated the active isoform likely contains an intrachain disulfide bridge between Cys86 and Cys95.

Conclusions:

• r-hGMF-beta requires oxidative refolding to achieve biological activity.
• The active conformation of r-hGMF-beta is characterized by a specific disulfide bridge (Cys86-Cys95).
• This finding is crucial for understanding GMF-beta's function and for potential therapeutic applications.